EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

(NasdaqGM:EDAP), AUSTIN, Texas, August 25, 2025 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to participate in a fireside chat and host 1×1 investor meetings at the H.C. Wainwright 27th Annual Global Investment Conference, which is being held […]

Erdene Provides Update on Share Consolidation

Erdene Provides Update on Share Consolidation GlobeNewswire August 25, 2025 HALIFAX, Nova Scotia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX: ERD; MSE: ERDN; OTCQB: ERDCF) (“Erdene” or the “Company”) is pleased to provide an update on the proposed consolidation (the “Consolidation“) of Company's issued and outstanding common shares (the “Common Shares“)

Anfield To Commence Confirmation Drill Program at Its JD-7 Mine

Anfield To Commence Confirmation Drill Program at Its JD-7 Mine GlobeNewswire August 25, 2025 VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it has received approval for its Notice of Intent (“NOI”), through its wholly owned

Blockmate investee Hivello recognized in Forbes as leading DePIN innovator

Blockmate investee Hivello recognized in Forbes as leading DePIN innovator GlobeNewswire August 25, 2025 TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) — Blockmate Ventures Inc. (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH) (“Blockmate” or the “Company”) is pleased to announce that its investee, Hivello Holdings, has been featured in a Forbes article titled “DePIN Passive Income: 5

Yukon Metals Commences Inaugural Drill Program at Its Star River Project

Yukon Metals Commences Inaugural Drill Program at Its Star River Project GlobeNewswire August 25, 2025 VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF) (“Yukon Metals” or the “Company) is pleased to provide an update from its inaugural drill program at the 100%-owned, road-accessible, 720-hectare Star

Apollo Expands Project Team; Receives Drill Permit for Calico Silver Project

Apollo Expands Project Team; Receives Drill Permit for Calico Silver Project Company amends Langtry option and prepares to advance exploration and resource development programs GlobeNewswire August 25, 2025 VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Apollo Silver Corp. (“Apollo” or the “Company“) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce a number of positive

TradeProfina Unveils Revolutionary Algorithm for Instant Market Reversal Alerts

TradeProfina Unveils Revolutionary Algorithm for Instant Market Reversal Alerts GlobeNewswire August 25, 2025 Austin, Texas, Aug. 25, 2025 (GLOBE NEWSWIRE) — TradeProfina, a recognized leader in real-time market analytics, has officially rolled out its newest trading algorithm designed to capture market reversals as they occur. The system provides traders with instant buy and sell alerts

Sionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of Cystic Fibrosis

Sionna Therapeutics Announces First Subjects Dosed in Phase 1 Trial Evaluating NBD1 Stabilizer, SION-451, in Proprietary Dual Combinations in Development for the Treatment of Cystic Fibrosis Dosing initiated for SION-451 combined with SION-2222 and SION-451 combined with SION-109 in healthy volunteers; topline data anticipated in mid-2026 GlobeNewswire August 25, 2025 WALTHAM, Mass., Aug. 25, 2025

New Evidence Published Supporting Use of DecisionDx(R)-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma

New Evidence Published Supporting Use of DecisionDx(R)-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma GlobeNewswire August 25, 2025 New validation study shows DecisionDx-SCC significantly outperforms current staging systems in predicting risk of local recurrence and metastasis for NCCN high-risk patients Clinician survey confirms test results align with

Scroll to Top